Inspiration Healthcare Group

IHC · AIM · Health Care · mcap £17m · 18.5p

Inspiration Healthcare designs and distributes medical devices for neonatal and respiratory care, including its own SLE ventilators, plus third-party products. It sells mainly to health services in the UK and export markets.

Target	Promise	Said	Status
2025
30 Apr 2025	Meet alternate debt covenants	1 May 2024	✗ Missed · target changed
	“Alternate covenants have been agreed until 30 April 2025 which will need to be met” Result Nov 2024 lender waived October test and reset covenants lower through January 2026. “the Company's lender, HSBC, has granted a waiver in respect of the EBITDA covenant for the 31 October 2024 test date and a reset of such covenant at a lower level for the 31 January 2025 test date. The interest cover and net leverage covenants have also been reset for the period through to 31 January 2026.”4 Nov 2024 · Grant of Covenant Waiver and Covenant Reset
Today · 15 Oct 2026
2027
FY27	Launch new SLE branded neonatal consumables range	28 May 2025	✗ Missed · target changed
	“New range of SLE branded consumables on track for launch in FY27” Also stated 7 Oct 2025 · 16 Jun 2026 Result Launch moved from later in 2025 to FY27 (year to January 2027). “New range of SLE branded consumables on track for launch in FY27”16 Jun 2026 · Final Results
late 2027 FDA filing	Launch SLE6000 neonatal ventilator in the US, following FDA clearance	3 Oct 2023	✗ Missed · target changed
	“expected to lead to product clearance and launch in H1 2027” Also stated 4 Jan 2024 · 7 Oct 2025 · 16 Jun 2026 Result Launch slipped from H2 2024/FY25 to H1 2027, then FDA filing pushed to late 2027. “Advancing US market entry for SLE6000 ventilator, completing testing for FDA submission in H2 2026 and preparing for H1 2027 launch”7 Oct 2025 · Half-year Results “we now anticipate FDA filing in late 2027, with clearance in H1 2028”16 Jun 2026 · Final Results